Prevalence and clinicopathological associations of HER2 expression in non-small cell lung cancer: a retrospective study in Jordanian patients

Autor: Ola Abu Al Karsaneh, Arwa Al Anber, Mohammad ALQudah, Sahar Al-Mustafa, Hussien AlMa’aitah, Maher Sughayer

Publikováno v: Diagnostic Pathology, Vol 18, Iss 1, Pp 1-13 (2023)

Abstract Background Human epidermal growth factor receptor 2 (HER2), a promising therapeutic target, can be mutated, amplified, or overexpressed in different malignancies, including non-small cell lung cancer (NSCLC). Although these alterations showe

Externí odkaz: https://doaj.org/article/1288b005f19f482c98bebcba611f7808

Mu Opioid Receptor 1 (MOR-1) Expression in Colorectal Cancer and Oncological Long-Term Outcomes: A Five-Year Retrospective Longitudinal Cohort Study

Autor: Francisco Giner, Maria Pilar Argente-Navarro, Lola Ruiz-Boluda, Amparo Belltall, Juan P. Cata, Luis Sánchez-Guillén, Guido Mazzinari, Anabel Marqués-Marí, Oscar Diaz-Cambronero, Pilar Eroles

Publikováno v: Cancers
Volume 12
Issue 1
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Cancers, 12(1):134. Multidisciplinary Digital Publishing Institute (MDPI)
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Cancers, Vol 12, Iss 1, p 134 (2020)

Preclinical evidence has shown increased expression of mu opioid receptor 1 (MOR-1) in colorectal cancer although its association with disease-free and overall survival (DFS and OS) has not been investigated. We hypothesized that MOR-1 was overexpres

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09d62b6c08e989baea130cb1fce2f52f